LOS ANGELES, Sept. 27, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) shines a light on a unique opportunity for investors with significant losses to spearhead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) under the ticker OM.
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
Should you desire to take the helm as the lead plaintiff in the Outset Medical lawsuit, make your mark by submitting your contact particulars at www.glancylaw.com/cases/Outset-Medical-Inc-1/. Alternatively, reach out to the seasoned team at GPM led by Charles H. Linehan at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to delve deeper into your rights.
The grievance filed contends, throughout the Class Period, that Defendants failed to unveil to investors a myriad of essential information, including misleading marketing of Tablo products for continuous renal replacement therapy, insinuating a potential additional FDA application, and the inherent risks of sales cessation without FDA nod, leading to adverse impacts on revenue growth and the credibility of the Company’s positive assertions.
For further updates, join us on LinkedIn, Twitter, or Facebook.
To partake in the class action, you need not act now; you can opt for legal counsel or stay passive and remain an absent member of the case. To gain more insights or seek answers to queries regarding this lawsuit, please connect with Charles Linehan, Esquire, of GPM, at 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by dialing 310-201-9150 or Toll-Free at 888-773-9224, sending an email to shareholders@glancylaw.com, or visiting our website at www.glancylaw.com. For inquiries via email, ensure to include your mailing address, telephone number, and share quantity.
Bear in mind that this press release may constitute Attorney Advertising in select jurisdictions under relevant laws and ethical standards.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-302261382.html
SOURCE Glancy Prongay & Murray LLP
Market News and Data brought to you by Benzinga APIs
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
